lat8881
Small moleculeexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 9, 2019 (NCT03865953)
Timeline
Indications
Mechanism of action
- Growth hormone receptorAGONIST
GHR agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05298306 | Phase 1 | May 17, 2022 | Lateral Pharma Pty Ltd, Southern Star Research Pty Ltd., University of Adelaide |
| NCT04153409 | Phase 2 | Sep 24, 2019 | Emeritus Research, Lateral Pharma Pty Ltd |
| NCT03865953 | Phase 2 | Apr 9, 2019 | Lateral Pharma Pty Ltd, University of Bristol |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lateral Pharma Pty Ltd | For profit | 3 | 3 | 2 | 2019 |
| Emeritus Research | For profit | 1 | 0 | 1 | 2019 |
| Southern Star Research Pty Ltd. | For profit | 1 | 0 | 1 | 2022 |
| University of Adelaide | Academic/Hospital | 1 | 0 | 1 | 2022 |
| University of Bristol | Academic/Hospital | 1 | 0 | 1 | 2019 |
5 organizations
Page 1 / 1